MetLife Buy Hold or Sell Recommendation

MET -- USA Stock  

Earning Report: October 30, 2019  

Considering 30-days investment horizon, and your above average risk tolerance our recommendation regarding MetLife is 'Strong Hold'. Macroaxis provides MetLife buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding MetLife positions. The advice algorithm takes into account all of MetLife available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from MetLife buy-and-hold prospective. Please see also MetLife Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.

Time Horizon

Risk Tolerance

Symbol
Execute Advice
Sell MetLifeBuy MetLife
Strong Hold

Volatility

Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Piotroski F Score

Financial Leverage

For the selected time horizon MetLife has a risk adjusted performance of (0.043217), jensen alpha of (0.05), total risk alpha of (0.046647), sortino ratio of 0.0 and treynor ratio of (0.06)
Macroaxis advice tool can be used to complement MetLife buy, hold, or sell recommendation provided by experts. It analyzes the firm potential to grow against your specific risk preferences and investment horizon. To make sure MetLife is not overpriced, please verify all MetLife fundamentals including its Debt to Equity, and the relationship between EBITDA and Earnings Per Share . Given that MetLife has Price to Earning of 7.75 , we recommend you check MetLife market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your last-minute risk tolerance and investing horizon.

MetLife Trading Alerts and Improvement Suggestions

MetLife generates negative expected return over the last 30 days
MetLife has high likelihood to experience some financial distress in the next 2 years
MetLife has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial commitments
About 62.0% of the company outstanding shares are owned by corporate insiders
Latest headline from MacroaxisInsider: Acquisition by Robert Hubbard of 184 shares of MetLife subject to Rule 16b-3

MetLife current analysts recommendations

Target Median Price54.00
Target Mean Price52.71
Recommendation Mean2.40
Target High Price63.00
Number Of Analyst Opinions17
Target Low Price41.00

MetLife Returns Distribution Density

Mean Return0.07Value At Risk2.71
Potential Upside2.20Standard Deviation1.54
 Return Density 
      Distribution 

Institutional Investors

Security TypeSharesValue
Robeco Institutional Asset Management BvCommon Shares1.7 M81.4 M
Pggm InvestmentsCommon Shares1.2 M56.5 M
Assenagon Asset Management SaPut Options1.1 M51.9 M
Envestnet Asset Management IncCommon Shares972.7 K45.9 M
Douglas Lane Associates LlcCommon Shares717.9 K33.9 M
Assenagon Asset Management SaCall Options600 K28.3 M
Zurcher Kantonalbank Zurich CantonalbankCommon Shares528.6 K24.9 M
Churchill Management CorpCommon Shares395.1 K18.6 M
Nisa Investment Advisors LlcCommon Shares313.4 K14.8 M

MetLife Greeks

α
Alpha over DOW
=0.05
β
Beta against DOW=1.37
σ
Overall volatility
=1.57
Ir
Information ratio =0.04

MetLife Volatility Alert

MetLife exhibits very low volatility with skewness of -0.54 and kurtosis of 0.36. However, we advise investors to further study MetLife technical indicators to make sure all market info is available and is reliable.
    
 Better Than Average     
    
 Worse Than Average Compare MetLife to competition

MetLife Fundamental Vs Peers

FundamentalsMetLifePeer Average
Return On Equity0.05 (0.31) 
Return On Asset0.0036 (0.14) 
Profit Margin0.06 (1.27) 
Operating Margin13.57 (5.51) 
Current Valuation114.39 B16.62 B
Shares Outstanding936.45 M571.82 M
Shares Owned by Insiders61.88 10.09 
Number of Shares Shorted12.46 M4.71 M
Price to Earning7.75 28.72 
Price to Book0.69 9.51 
Price to Sales0.67 11.42 
Revenue65.72 B9.43 B
Gross Profit20 B27.38 B
EBITDA8.92 B3.9 B
Net Income5.92 B570.98 M
Cash and Equivalents27.89 B2.7 B
Cash per Share29.79 5.01 
Total Debt97.69 B5.32 B
Debt to Equity152.50 48.70 
Current Ratio1.07 2.16 
Book Value Per Share38.58 1.93 K
Cash Flow from Operations9.15 B971.22 M
Short Ratio1.70 4.00 
Earnings Per Share6.07 3.12 
Price to Earnings To Growth1.24 4.89 
Number of Employees58 K18.84 K
Beta0.89-0.15
Market Capitalization44.09 B19.03 B
Total Asset877.93 B29.47 B
Retained Earnings18.89 B9.33 B
Five Year Return3.24
Last Dividend Paid1.76
   Acquisition by Robert Hubbard of 184 shares of MetLife subject to Rule 16b-3 [view details]
Search macroaxis.com